Trial
NCT02780583
Treatment of Macrophage Activation Syndrome (MAS) With Anakinra
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
Macrophage Activation Syndrome
Intervention
kineret
Why stopped
no further funding to continue, investigator relocated, no replacement found to continue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-01